Lupin launches Formoterol Fumarate Inhalation Solution in US

Lupin launches Formoterol Fumarate Inhalation Solution in US

by admin- Tuesday, November 29th, 2022 03:19:45 PM

 

Global pharma primary Lupin announced the release of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL in line with Unit-Dose Vial, to market a normal equivalent of Perforomist Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty, L.P.

Formoterol Fumarate Inhalation Solution (RLD Perforomist®) had estimated annual income of USD 268 million inside the US.

News Updates